there were 575 patients enrolled in these clinical trials , and preliminary analyses of data from 384 of these patients demonstrate a virtual absence of placebo response , a very low rate of premature discontinuation , and for patients receiving clomipramine , a statistically and clinically significant improvement in ocd symptoms ( 40 % -45 % mean improvement with clomipramine vs. 4 % -5 % mean improvement with placebo ) .
C0028768
ocd
C0009010
clomipramine